1. Dr Surveen Ghumman MD
Specialist
Vardhaman Mahavir Medical College & Safdarjang
Hospital, Delhi
2. Premature ovarian failure ( POF)
Primary ovarian insufficiency
Premature menopause
Early menopause
POF is a condition characterized by
amenorrhea, hypoestrogenism, and elevated
serum gonadotropin levels in women younger
than 40 years.
3. 1 – 4 % of women
1 case per 1000 women by age 30,
1 case per 250 women by age 35
1 case per 100 women by age 40.
Primary amenorrhea - 10-28% of women
Secondary amenorrhea - 4-18% of women
4. 1. Induced (iatrogenic) POF/POI
2. Spontaneous POF/POI – Cause usually
unknown
Two Mechanisms
Follicular Depletion
Decreased germ cell migration
Accelerated atretic process
Acquired ovarian disease
Follicular Dysfunction
9. Last spontaneous menstrual cycle
Prior pelvic surgeries, irradiation, or chemotherapy
Symptoms of adrenal insufficiency:
Orthostatic hypotension
Skin hyperpigmentation
Unexplained weakness
Salt craving
Abdominal pain
Anorexia
Symptoms of hypothyroidism
Family history of POF, male mental retardation,
autoimmune disorders
Symptoms of estrogen deprivation
10. Signs of hypoestrogenism
Enlarged ovaries versus nonpalpable ovaries
Physical stigmata of Turner syndrome/other genetic syndromes:
Short stature
Webbed neck
Low position of the ears
Low posterior hairline
Cubitus valgus
Shield chest
Short IV and V metacarpals
Signs of autoimmune diseases, Addison disease, and
hypothyroidism
11. 1. Tests to establish the diagnosis of POF/POI,
2. Tests that help clarify the etiology,
3. Screening tests for other diseases known to have
higher prevalence among women with POF/POI.
4. Tests to establish effect of POF
Pregnancy test
FSH , LH, estradiol (FSH value - over 40 mIU/ml on at least two
occasions over a four weeks period)
Standard blood chemistry - Fasting glucose, electrolytes,
creatinine
Karyotype
Test for fragile X chromosome (FMR1 premutation)
Bone density by dual-energy x-ray absorptiometry (DEXA) scan
USG ovary
13. Short term
Vascular symptoms like hot flushes, night sweats,
Headaches
Vaginal dryness
Dyspareunea
Urgency and stress urinary incontinence
Irritability
Forgetfulness
Poor concentration
Insomnia
Long term
Infertility
Osteoporosis
Cardiovascular disease
Stroke
Psychological Impact - Depression
14. Pregnancy
Secondary ovarian insufficiency/failure due to the following:
Eating disorder
Extreme physical exercise
Prolactinoma and other conditions causing hyperprolactinemia
Pituitary and hypothalamic tumors
Hypothalamic and pituitary infiltrative and inflammatory processes
Pituitary hemorrhage
Systemic diseases, including other endocrine disorders
Medications
Hyperandrogenic conditions due to the following:
Polycystic ovarian syndrome
Congenital adrenal hyperplasia
Ovarian or adrenal androgen-producing tumors
Ovarian hyperthecosis
Outflow tract abnormalities
Pseudo premature ovarian failure due to the following:
Gonadotropin-producing pituitary adenoma
Antibodies to gonadotropins
15. Hormone replacement therapy (HRT)
Cyclical HRT with estrogens and progestins to relieve the
symptoms of estrogen deficiency and to maintain bone density.
Estrogens
Estrogens can be administered orally or transdermally.
Higher doses than those for post menopausal women may be
needed to achieve adequate estrogenization of the vaginal
epithelium in young women and help maintain age-appropriate
bone density.
The estrogens can be administered continuously or cyclically.
Estrogen replacement therapy does not prevent ovulation and
conception in these patients
16. Progestins
Cyclically, 10-14 days each month, to prevent endometrial
hyperplasia
If an expected withdrawal bleeding is missing, a pregnancy test
should be performed. 5-10% chance of spontaneous pregnancy
The recommended regimens
Medroxyprogesterone 10 mg daily for 10-12 days each month or
Micronized progesterone 200 mg daily for 10-12 days each month.
Androgens
13% have levels below normal.Given for short periods.
Androgen replacement could be carefully considered for women with
Addisons disease
Persistent fatigue,
Low libido,
Poor well being despite adequate estrogen replacement
Available medications include oral methyl testosterone 1.25-2.5
mg/d, injectable testosterone esters 50 mg every 6 weeks
intramuscularly, testosterone implants
17. Steroids for autoimmune POF not indicated as
high doses needed lead to side effects like
osteonecrosis.
Unproven treatments to restore fertility should
be avoided
Gonadotropin therapy carries a theoretical risk
of exacerbating autoimmune POF
ART
Oocyte donation
Embryo adoption
Surrogacy
Ovarian cryopreservation in Iatrogenic POF
Adoption
18. Endocrinologist consultation may be indicated for
hypothyroidism or adrenal insufficiency.
Psychological evaluation and counseling.
Genetic counseling may be needed in some.
Referral for eye care if symptoms of dry eye.
19. Diet
Elemental Calcium : 1200-1500 mg day.
Adequate intake of vitamin D.
Activity
Weight-bearing exercises for 30 minutes per
day, at least 3 days per week, to improve
muscle strength and maintain bone mass.
Participation in outdoor sports is strongly
recommended.
20. Women with POF/POI should be educated on
the nature of their disease and the current
research efforts. The mere understanding of
the problem helps patients cope better.
Support Web sites are available – -
International Premature Ovarian Failure
Association
21. Annual followup to
Monitor HRT.
Symptoms and signs of thyroid disease and adrenal insufficiency .
TSH levels - checked every 3-5 years (every year if
antiperoxidase antibody test is positive).
Adrenal antibodies positive on her initial evaluation, even if all
adrenal function tests normal - annual ACTH stimulation test.
Adrenal antibody tests negative still continue to carry higher
than normal risk for adrenal insufficiency - adrenal antibody
test performed every 3-5 years.
Patients with secondary ovarian failure should be monitored
for manifestations of the underlying hypothalamic/pituitary
pathology (progression of space-occupying lesions and
development/progression of hypopituitarism).
22. POF is a challenging issue as women
are delaying having families and this
emotionally distressing problem
must be dealt, on both the physical
and psychological platform.
24. DR.Maninder Ahuja
Chairperson Geriatric Gynecology committee
Author :
Dr.surveen Ghuman
Thanks to all those who would carry this
torch further.